SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-216866
Filing Date
2022-08-10
Accepted
2022-08-10 08:35:21
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d280159ds3.htm S-3 492837
2 EX-1.2 d280159dex12.htm EX-1.2 183942
3 EX-4.4 d280159dex44.htm EX-4.4 340930
4 EX-4.5 d280159dex45.htm EX-4.5 339137
5 EX-4.6 d280159dex46.htm EX-4.6 34345
6 EX-4.7 d280159dex47.htm EX-4.7 40472
7 EX-5.1 d280159dex51.htm EX-5.1 30317
8 EX-23.1 d280159dex231.htm EX-23.1 1266
9 EX-FILING FEES d280159dexfilingfees.htm EX-FILING FEES 70312
10 GRAPHIC g280159dsp216.jpg GRAPHIC 2420
11 GRAPHIC g280159g04r04.jpg GRAPHIC 63094
  Complete submission text file 0001193125-22-216866.txt   1625058
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266731 | Film No.: 221150534
SIC: 2834 Pharmaceutical Preparations